Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

29.42 +0.23 (+0.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 414,943
Open 29.08
Bid (Size) 29.41 (4)
Ask (Size) 29.45 (29)
Prev. Close 29.19
Today's Range 28.98 - 29.78
52wk Range 20.39 - 53.95
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the generic pharmaceuticals industry, including Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 Profitable Stocks We Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory

Performance

YTD
-19.1%
-19.1%
1 Month
+41.3%
+41.3%
3 Month
+13.2%
+13.2%
6 Month
+2.1%
+2.1%
1 Year
-35.2%
-35.2%

More News

Read More
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
Via ACCESS Newswire
Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Value Stock with Strong Fundamentals and Undervalued Potential
Via Chartmill
Earnings Scheduled For August 7, 2025
Via Benzinga
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
Via StockStory
Topics Bonds Economy Lawsuit
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
Via Benzinga
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
Via ACCESS Newswire
Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
Via ACCESS Newswire
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6%
Via StockStory
Amphastar (AMPH) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Supply Chain
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
Via ACCESS Newswire
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Find Risky
Via StockStory
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7th, 2025
Via ACCESS Newswire
3 Low-Volatility Stocks with Questionable Fundamentals
Via StockStory
Topics Supply Chain
Fortrea, Azenta, Bio-Techne, 10x Genomics, and Amphastar Pharmaceuticals Stocks Trade Up, What You Need To Know
Via StockStory
Topics Stocks World Trade
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know
Via StockStory
Topics Lawsuit World Trade
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters
Via ACCESS Newswire
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know
Via StockStory
Topics ETFs Stocks World Trade
1 Healthcare Stock on Our Buy List and 2 to Approach with Caution
Via StockStory
Topics Stocks
AMPHASTAR PHARMACEUTICALS INC (NASDAQ:AMPH) – An Undervalued Stock Worth Considering
Via Chartmill
1 Healthcare Stock with Solid Fundamentals and 2 to Ignore
Via StockStory
Topics Stocks
3 Value Stocks with Questionable Fundamentals
Via StockStory
AMPHASTAR PHARMACEUTICALS INC (NASDAQ:AMPH) – An Undervalued Stock Worth Considering
Via Chartmill
3 Russell 2000 Stocks with Questionable Fundamentals
Via StockStory

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 29.42
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 09/05/25 04:00 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.41B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.